Header Logo

Connection

James Moy to Immunotherapy

Back to Details
This is a "connection" page, showing publications James Moy has written about Immunotherapy.
James Moy
Connection Strength
0.600
Immunotherapy
  1. Efficacy and Safety of Human Intravenous Immunoglobulin 10% (Panzyga?) in Patients with Primary Immunodeficiency Diseases: a Two-Stage, Multicenter, Prospective, Open-Label Study. J Clin Immunol. 2017 Aug; 37(6):603-612.
    View in: PubMed
    Score: 0.600
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.